Coya Therapeutics, Inc. (COYA)

4.59 -5.56% (-0.27)

Over 5Y: +0.4%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

4 6 8 10
2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q1 '22 — Operating Cash Flow: -2M Q1 '22 — Net Income: -1.7M Q2 '22 — Operating Cash Flow: -1.4M Q2 '22 — Net Income: -3.4M Q3 '22 — Operating Cash Flow: -1.6M Q3 '22 — Net Income: -4M Q4 '22 — Operating Cash Flow: -2.2M Q4 '22 — Net Income: -3.1M Q1 '23 — Revenue: 0 Q1 '23 — Operating Cash Flow: -3.9M Q1 '23 — Net Income: -2.7M Q2 '23 — Revenue: 0 Q2 '23 — Operating Cash Flow: -2.9M Q2 '23 — Net Income: -3.1M Q3 '23 — Revenue: 0 Q3 '23 — Operating Cash Flow: -2.2M Q3 '23 — Net Income: -3.4M Q4 '23 — Revenue: 6M Q4 '23 — Operating Cash Flow: -2.2M Q4 '23 — Net Income: 1.3M Q1 '24 — Revenue: 126.8K Q1 '24 — Operating Cash Flow: 2.1M Q1 '24 — Net Income: -5.1M Q2 '24 — Revenue: 3.4M Q2 '24 — Operating Cash Flow: -4.6M Q2 '24 — Net Income: -2.9M Q3 '24 — Revenue: 0 Q3 '24 — Operating Cash Flow: -5.5M Q3 '24 — Net Income: -4M Q4 '24 — Revenue: 2K Q4 '24 — Operating Cash Flow: -2.4M Q4 '24 — Net Income: -2.9M Q1 '25 — Revenue: 257.9K Q1 '25 — Operating Cash Flow: -2.8M Q1 '25 — Net Income: -7.3M Q2 '25 — Revenue: 163.6K Q2 '25 — Operating Cash Flow: -5.8M Q2 '25 — Net Income: -6.1M Q3 '25 — Revenue: 3.6M Q3 '25 — Operating Cash Flow: -1.1M Q3 '25 — Net Income: -2.1M Q4 '25 — Revenue: 4M Q4 '25 — Operating Cash Flow: -1M Q4 '25 — Net Income: -5.7M Q1 '26 — Revenue: 251.1K Q1 '26 — Operating Cash Flow: -6.2M Q1 '26 — Net Income: -7.2M Q2 '26 — Revenue: 243.7K Q2 '26 — Operating Cash Flow: -7.4M Q2 '26 — Net Income: -6.6M -6M -3M 0 3M 6M 9M
Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 66.3%
OE margin -262.3%
Oper. margin -288.7%
ROIC -19250.1%
Accruals -12.6%
EBITDA margin -288.5%
FCF margin -196.1%
OCF margin -196.1%
Profit margin -270.2%
ROA -45.8%
ROCE -52.9%
ROE -50.1%
Capex / sales —
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.0
RPO / sales 0.15×
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.4
Current ratio 20.6×
ND/EBITDA —
Cash runway 2.7 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 13.4×
F-score 2.6 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.6
Sales/sh Y/Y +1624.8%
Sales Q/Q +49.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.